Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
An index aggregates price movement to summarize market direction, helping traders and investors gauge momentum and risk.
28,440 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
A no-action relief granted to Phantom allows crypto wallets to function as consumer interfaces for regulated derivati...
VCR is down about 9% year-to-date, but nearly 40% of its holdings sit in Amazon and Tesla, reshaping the fund’s risk ...
The iShares MSCI South Korea ETF has surged on AI memory demand, with Samsung Electronics and SK Hynix driving a hidd...
Tim Cook's travels to China are more than diplomacy. This piece outlines how what cook's trip china could mean for Ap...
Brookfield is pursuing corporate simplification by merging its insurance arm with the parent company. This move could...
As market volatility persists in 2026, a tax-advantaged Roth approach could dramatically lift after-tax income from a...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...
Coke trading steepest premium to Pepsi in years has market watchers asking what’s next. This article breaks down the ...
Two tech giants sit at the edge of unprecedented scale. This article weighs Nvidia and Alphabet's growth engines, eva...
If the Fed delivers a single rate move in 2026, bond ETFs could react in surprising ways. This article explains what ...
When a stock climbs 15% after a fund trims its position, investors should look beyond the headline. This article brea...